| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 52 | 2023 | 1469 | 4.700 |
Why?
|
| Genome-Wide Association Study | 188 | 2024 | 12661 | 4.620 |
Why?
|
| Polymorphism, Single Nucleotide | 196 | 2024 | 15908 | 3.910 |
Why?
|
| Aorta, Abdominal | 26 | 2020 | 625 | 3.650 |
Why?
|
| Aortic Diseases | 20 | 2022 | 735 | 3.500 |
Why?
|
| Coronary Artery Disease | 86 | 2023 | 6403 | 3.320 |
Why?
|
| Cardiovascular Diseases | 127 | 2023 | 15498 | 3.270 |
Why?
|
| Coronary Disease | 47 | 2022 | 5911 | 2.760 |
Why?
|
| Genetic Predisposition to Disease | 132 | 2024 | 17878 | 2.590 |
Why?
|
| Atherosclerosis | 38 | 2023 | 3400 | 2.390 |
Why?
|
| Genetic Loci | 42 | 2021 | 2624 | 2.290 |
Why?
|
| Mendelian Randomization Analysis | 25 | 2023 | 1007 | 2.220 |
Why?
|
| Aorta, Thoracic | 17 | 2022 | 1096 | 1.850 |
Why?
|
| Quantitative Trait Loci | 32 | 2024 | 2112 | 1.810 |
Why?
|
| Myocardial Infarction | 58 | 2024 | 11458 | 1.800 |
Why?
|
| Coronary Vessels | 24 | 2019 | 3095 | 1.770 |
Why?
|
| Genome, Human | 36 | 2022 | 4421 | 1.570 |
Why?
|
| Carotid Artery Diseases | 14 | 2021 | 877 | 1.530 |
Why?
|
| Aortography | 7 | 2018 | 421 | 1.480 |
Why?
|
| von Willebrand Factor | 15 | 2022 | 676 | 1.480 |
Why?
|
| Genetic Variation | 53 | 2024 | 6561 | 1.420 |
Why?
|
| Blood Pressure | 55 | 2024 | 8473 | 1.380 |
Why?
|
| Fibrinogen | 16 | 2022 | 887 | 1.370 |
Why?
|
| Risk Factors | 224 | 2024 | 74128 | 1.350 |
Why?
|
| Intra-Abdominal Fat | 24 | 2017 | 612 | 1.270 |
Why?
|
| Male | 454 | 2024 | 360402 | 1.220 |
Why?
|
| Middle Aged | 368 | 2024 | 220603 | 1.210 |
Why?
|
| Calcium | 18 | 2020 | 5717 | 1.190 |
Why?
|
| Veterans | 21 | 2024 | 2649 | 1.180 |
Why?
|
| Humans | 642 | 2024 | 760740 | 1.180 |
Why?
|
| Heart Valve Diseases | 10 | 2023 | 1028 | 1.140 |
Why?
|
| Female | 426 | 2024 | 392203 | 1.070 |
Why?
|
| Tunica Intima | 11 | 2011 | 458 | 1.050 |
Why?
|
| Cohort Studies | 146 | 2022 | 41464 | 1.040 |
Why?
|
| Tomography, X-Ray Computed | 54 | 2017 | 20556 | 1.040 |
Why?
|
| Arteriosclerosis | 12 | 2004 | 1056 | 1.020 |
Why?
|
| Hypertrophy, Left Ventricular | 10 | 2018 | 851 | 1.010 |
Why?
|
| Heart Rate | 21 | 2023 | 4181 | 0.990 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 8 | 2021 | 277 | 0.990 |
Why?
|
| Cholesterol, LDL | 21 | 2022 | 2378 | 0.990 |
Why?
|
| Phenotype | 84 | 2022 | 16572 | 0.980 |
Why?
|
| Genotype | 70 | 2021 | 12977 | 0.980 |
Why?
|
| Coronary Angiography | 18 | 2019 | 4470 | 0.970 |
Why?
|
| Aged | 270 | 2024 | 169092 | 0.970 |
Why?
|
| Factor VIII | 6 | 2022 | 348 | 0.960 |
Why?
|
| Genomics | 27 | 2022 | 5822 | 0.960 |
Why?
|
| Biological Specimen Banks | 3 | 2020 | 778 | 0.950 |
Why?
|
| Carotid Artery, Common | 6 | 2011 | 175 | 0.950 |
Why?
|
| Hypertension | 46 | 2024 | 8532 | 0.940 |
Why?
|
| Angina, Unstable | 9 | 2006 | 888 | 0.920 |
Why?
|
| Genetic Linkage | 18 | 2009 | 2340 | 0.870 |
Why?
|
| Plaque, Atherosclerotic | 9 | 2022 | 1533 | 0.870 |
Why?
|
| Factor VII | 7 | 2022 | 139 | 0.860 |
Why?
|
| Gene Frequency | 33 | 2022 | 3601 | 0.860 |
Why?
|
| Lipids | 17 | 2022 | 3332 | 0.860 |
Why?
|
| Subcutaneous Fat, Abdominal | 8 | 2014 | 91 | 0.840 |
Why?
|
| Obesity | 48 | 2023 | 12934 | 0.840 |
Why?
|
| Heart Ventricles | 13 | 2017 | 3796 | 0.830 |
Why?
|
| Quantitative Trait, Heritable | 12 | 2014 | 540 | 0.830 |
Why?
|
| Massachusetts | 49 | 2018 | 8835 | 0.810 |
Why?
|
| Tunica Media | 7 | 2011 | 110 | 0.800 |
Why?
|
| Aortic Valve Stenosis | 7 | 2024 | 2003 | 0.800 |
Why?
|
| C-Reactive Protein | 15 | 2018 | 3820 | 0.790 |
Why?
|
| Insulin Resistance | 16 | 2021 | 3954 | 0.790 |
Why?
|
| Genetic Pleiotropy | 6 | 2022 | 181 | 0.770 |
Why?
|
| Ventricular Function, Left | 14 | 2024 | 3873 | 0.730 |
Why?
|
| Forensic Pathology | 8 | 2017 | 23 | 0.710 |
Why?
|
| Risk Assessment | 55 | 2023 | 23974 | 0.690 |
Why?
|
| Leukocytes | 11 | 2020 | 2024 | 0.690 |
Why?
|
| Predictive Value of Tests | 39 | 2022 | 15250 | 0.690 |
Why?
|
| Adult | 217 | 2023 | 220995 | 0.680 |
Why?
|
| R-SNARE Proteins | 6 | 2016 | 74 | 0.680 |
Why?
|
| Prevalence | 47 | 2022 | 15702 | 0.680 |
Why?
|
| Heart Conduction System | 10 | 2018 | 992 | 0.670 |
Why?
|
| Heart Failure | 19 | 2024 | 11670 | 0.660 |
Why?
|
| Aortic Valve | 9 | 2023 | 1955 | 0.650 |
Why?
|
| Electrocardiography | 31 | 2018 | 6346 | 0.650 |
Why?
|
| Hypercholesterolemia | 4 | 2020 | 1141 | 0.640 |
Why?
|
| Incidence | 57 | 2022 | 21339 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 26 | 2022 | 12143 | 0.630 |
Why?
|
| Databases, Genetic | 12 | 2021 | 1742 | 0.630 |
Why?
|
| Hemostasis | 6 | 2020 | 469 | 0.620 |
Why?
|
| Sleep Apnea, Obstructive | 10 | 2008 | 1877 | 0.620 |
Why?
|
| Myocardial Contraction | 5 | 2018 | 1515 | 0.620 |
Why?
|
| Lipoprotein(a) | 5 | 2023 | 479 | 0.610 |
Why?
|
| Platelet Aggregation | 8 | 2018 | 771 | 0.610 |
Why?
|
| Venous Thromboembolism | 9 | 2022 | 1866 | 0.610 |
Why?
|
| Genetic Markers | 15 | 2020 | 2601 | 0.600 |
Why?
|
| Polymorphism, Genetic | 16 | 2019 | 4242 | 0.600 |
Why?
|
| American Heart Association | 13 | 2022 | 1039 | 0.600 |
Why?
|
| Multifactorial Inheritance | 13 | 2024 | 1381 | 0.600 |
Why?
|
| Hospitalists | 1 | 2022 | 294 | 0.580 |
Why?
|
| Blood Cells | 3 | 2015 | 305 | 0.580 |
Why?
|
| Histone Deacetylases | 3 | 2019 | 719 | 0.580 |
Why?
|
| Blood Glucose | 13 | 2017 | 6390 | 0.570 |
Why?
|
| Heart Diseases | 16 | 2017 | 2778 | 0.570 |
Why?
|
| Aging | 19 | 2020 | 8700 | 0.570 |
Why?
|
| Chromosome Mapping | 15 | 2022 | 4611 | 0.570 |
Why?
|
| Alleles | 29 | 2021 | 6861 | 0.560 |
Why?
|
| Dyslipidemias | 10 | 2023 | 868 | 0.560 |
Why?
|
| Body Mass Index | 41 | 2022 | 12942 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2013 | 535 | 0.540 |
Why?
|
| Lipoproteins, LDL | 4 | 2023 | 642 | 0.540 |
Why?
|
| Aged, 80 and over | 91 | 2021 | 58919 | 0.530 |
Why?
|
| Multivariate Analysis | 29 | 2019 | 12043 | 0.530 |
Why?
|
| Apolipoprotein C-I | 1 | 2016 | 13 | 0.530 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2021 | 829 | 0.530 |
Why?
|
| Kidney | 9 | 2021 | 7044 | 0.510 |
Why?
|
| Calcium-Binding Proteins | 5 | 2021 | 1066 | 0.510 |
Why?
|
| Autopsy | 5 | 2017 | 1008 | 0.510 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 1492 | 0.510 |
Why?
|
| Insulin | 13 | 2015 | 6593 | 0.500 |
Why?
|
| Splenic Artery | 1 | 2015 | 57 | 0.490 |
Why?
|
| Carotid Arteries | 7 | 2015 | 941 | 0.490 |
Why?
|
| Triglycerides | 17 | 2022 | 2459 | 0.490 |
Why?
|
| Ventricular Dysfunction, Left | 10 | 2022 | 2118 | 0.490 |
Why?
|
| Stroke | 25 | 2023 | 9715 | 0.480 |
Why?
|
| Diabetes Complications | 7 | 2021 | 1315 | 0.480 |
Why?
|
| Haplotypes | 12 | 2022 | 2713 | 0.480 |
Why?
|
| Muscle Contraction | 1 | 2019 | 1200 | 0.470 |
Why?
|
| Pulmonary Ventilation | 4 | 2003 | 372 | 0.470 |
Why?
|
| Genetic Association Studies | 16 | 2022 | 2734 | 0.460 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 6 | 2014 | 323 | 0.460 |
Why?
|
| Twins | 1 | 2015 | 340 | 0.460 |
Why?
|
| Repressor Proteins | 5 | 2020 | 2985 | 0.450 |
Why?
|
| Proportional Hazards Models | 31 | 2018 | 12448 | 0.450 |
Why?
|
| Kidney Failure, Chronic | 4 | 2021 | 2474 | 0.450 |
Why?
|
| von Willebrand Diseases | 1 | 2015 | 132 | 0.450 |
Why?
|
| Alternative Splicing | 3 | 2016 | 1088 | 0.450 |
Why?
|
| Cholesterol | 9 | 2023 | 2902 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2013 | 70 | 0.450 |
Why?
|
| Fetal Death | 1 | 2015 | 435 | 0.450 |
Why?
|
| Follow-Up Studies | 50 | 2021 | 39062 | 0.440 |
Why?
|
| Metabolome | 7 | 2016 | 988 | 0.440 |
Why?
|
| Blood Coagulation Factors | 2 | 2007 | 366 | 0.440 |
Why?
|
| Stroke Volume | 16 | 2024 | 5486 | 0.430 |
Why?
|
| Odds Ratio | 32 | 2019 | 9644 | 0.430 |
Why?
|
| Tomography, Spiral Computed | 4 | 2013 | 273 | 0.430 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 13 | 2017 | 3776 | 0.430 |
Why?
|
| Glucose Tolerance Test | 4 | 2012 | 1178 | 0.420 |
Why?
|
| Systole | 10 | 2016 | 935 | 0.420 |
Why?
|
| Pericardium | 7 | 2017 | 664 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 28 | 2021 | 22117 | 0.420 |
Why?
|
| Sex Factors | 33 | 2021 | 10549 | 0.410 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2013 | 697 | 0.410 |
Why?
|
| Adiposity | 11 | 2023 | 1879 | 0.410 |
Why?
|
| Students | 1 | 2023 | 1736 | 0.410 |
Why?
|
| Prospective Studies | 54 | 2022 | 54364 | 0.410 |
Why?
|
| Liver | 15 | 2021 | 7512 | 0.410 |
Why?
|
| Stillbirth | 1 | 2015 | 368 | 0.410 |
Why?
|
| Sleep, REM | 3 | 2005 | 595 | 0.410 |
Why?
|
| Receptors, Interleukin-6 | 3 | 2021 | 224 | 0.400 |
Why?
|
| Ventricular Remodeling | 4 | 2017 | 1265 | 0.400 |
Why?
|
| Venous Thrombosis | 3 | 2019 | 1303 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 2 | 5 | 2011 | 313 | 0.400 |
Why?
|
| Live Birth | 1 | 2015 | 510 | 0.400 |
Why?
|
| Mice, Inbred DBA | 4 | 2005 | 619 | 0.390 |
Why?
|
| Death, Sudden, Cardiac | 11 | 2018 | 1551 | 0.390 |
Why?
|
| Airway Obstruction | 2 | 2010 | 661 | 0.390 |
Why?
|
| Longitudinal Studies | 36 | 2024 | 14599 | 0.390 |
Why?
|
| Hemostatics | 2 | 2022 | 240 | 0.390 |
Why?
|
| Bilirubin | 4 | 2009 | 435 | 0.380 |
Why?
|
| Blood Proteins | 3 | 2021 | 1172 | 0.380 |
Why?
|
| Renal Dialysis | 2 | 2021 | 1795 | 0.380 |
Why?
|
| Lipoproteins, HDL | 4 | 2017 | 675 | 0.380 |
Why?
|
| Case-Control Studies | 39 | 2022 | 22153 | 0.380 |
Why?
|
| Abdominal Fat | 6 | 2010 | 221 | 0.380 |
Why?
|
| Alanine Transaminase | 4 | 2022 | 601 | 0.380 |
Why?
|
| Cardiomyopathies | 4 | 2018 | 1948 | 0.380 |
Why?
|
| Cholesterol, HDL | 12 | 2016 | 1810 | 0.380 |
Why?
|
| Age Factors | 32 | 2021 | 18381 | 0.380 |
Why?
|
| Prognosis | 41 | 2024 | 29601 | 0.370 |
Why?
|
| Adipose Tissue | 11 | 2017 | 3310 | 0.370 |
Why?
|
| United States | 70 | 2024 | 72292 | 0.370 |
Why?
|
| Protein Isoforms | 2 | 2015 | 1697 | 0.370 |
Why?
|
| Long QT Syndrome | 3 | 2014 | 466 | 0.370 |
Why?
|
| Thrombosis | 9 | 2022 | 2942 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 10 | 2016 | 4408 | 0.360 |
Why?
|
| Risk | 23 | 2020 | 9603 | 0.360 |
Why?
|
| Peripheral Arterial Disease | 5 | 2021 | 1271 | 0.360 |
Why?
|
| Linkage Disequilibrium | 14 | 2022 | 1994 | 0.360 |
Why?
|
| Glomerular Filtration Rate | 9 | 2021 | 2174 | 0.350 |
Why?
|
| Glucose Intolerance | 5 | 2013 | 575 | 0.350 |
Why?
|
| Skull Fractures | 1 | 2012 | 202 | 0.350 |
Why?
|
| Aneurysm, Ruptured | 1 | 2015 | 464 | 0.350 |
Why?
|
| Lacerations | 1 | 2012 | 147 | 0.350 |
Why?
|
| Metabolic Diseases | 4 | 2021 | 680 | 0.340 |
Why?
|
| Magnetic Resonance Imaging, Cine | 6 | 2016 | 1048 | 0.340 |
Why?
|
| Rib Fractures | 1 | 2011 | 128 | 0.340 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2018 | 2234 | 0.340 |
Why?
|
| Adult Children | 3 | 2006 | 103 | 0.340 |
Why?
|
| Genetic Testing | 12 | 2021 | 3533 | 0.340 |
Why?
|
| Chickens | 1 | 2012 | 858 | 0.330 |
Why?
|
| Vitamin K | 5 | 2011 | 313 | 0.330 |
Why?
|
| Apolipoproteins E | 5 | 2021 | 1443 | 0.330 |
Why?
|
| Gene Expression Profiling | 17 | 2021 | 9417 | 0.330 |
Why?
|
| Cardiovascular System | 3 | 2008 | 834 | 0.330 |
Why?
|
| Body Height | 5 | 2022 | 1565 | 0.330 |
Why?
|
| Time Factors | 28 | 2022 | 39908 | 0.330 |
Why?
|
| Smoking | 17 | 2021 | 9054 | 0.330 |
Why?
|
| Intermittent Claudication | 2 | 2010 | 304 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2022 | 36401 | 0.320 |
Why?
|
| Cholesterol Ester Transfer Proteins | 3 | 2021 | 113 | 0.320 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3634 | 0.320 |
Why?
|
| Blood Platelets | 9 | 2018 | 2478 | 0.320 |
Why?
|
| Logistic Models | 26 | 2017 | 13248 | 0.320 |
Why?
|
| Lod Score | 7 | 2018 | 600 | 0.310 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 2 | 2009 | 72 | 0.310 |
Why?
|
| Patient Discharge | 1 | 2022 | 3442 | 0.310 |
Why?
|
| Mass Screening | 5 | 2023 | 5425 | 0.310 |
Why?
|
| Vitamin D | 4 | 2017 | 3301 | 0.300 |
Why?
|
| Membrane Proteins | 14 | 2022 | 7847 | 0.300 |
Why?
|
| Inflammation Mediators | 6 | 2018 | 1884 | 0.300 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2005 | 978 | 0.300 |
Why?
|
| Mice, Inbred Strains | 3 | 2005 | 1759 | 0.300 |
Why?
|
| Molecular Epidemiology | 5 | 2016 | 470 | 0.300 |
Why?
|
| Gene Regulatory Networks | 7 | 2015 | 1745 | 0.300 |
Why?
|
| Arteries | 5 | 2022 | 1120 | 0.300 |
Why?
|
| Lipoprotein Lipase | 4 | 2018 | 133 | 0.290 |
Why?
|
| Insulin-Secreting Cells | 4 | 2013 | 898 | 0.290 |
Why?
|
| Carotid Artery, Internal | 3 | 2006 | 445 | 0.290 |
Why?
|
| Aorta | 7 | 2019 | 2041 | 0.290 |
Why?
|
| Blood Gas Analysis | 1 | 2008 | 379 | 0.290 |
Why?
|
| Biomedical Research | 4 | 2021 | 3426 | 0.290 |
Why?
|
| Glycemic Index | 1 | 2010 | 396 | 0.290 |
Why?
|
| Mitral Valve | 7 | 2017 | 1464 | 0.290 |
Why?
|
| Metacarpal Bones | 1 | 2008 | 75 | 0.280 |
Why?
|
| Pharmacogenetics | 6 | 2019 | 675 | 0.280 |
Why?
|
| Leukocyte Count | 6 | 2014 | 1597 | 0.280 |
Why?
|
| Fatty Acid Desaturases | 2 | 2020 | 100 | 0.280 |
Why?
|
| Mice | 41 | 2021 | 81368 | 0.280 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2022 | 4575 | 0.280 |
Why?
|
| Carotid Stenosis | 4 | 2007 | 859 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 4010 | 0.270 |
Why?
|
| Glucuronosyltransferase | 4 | 2009 | 132 | 0.270 |
Why?
|
| Heart | 10 | 2019 | 4403 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2017 | 638 | 0.270 |
Why?
|
| Linear Models | 18 | 2018 | 5866 | 0.270 |
Why?
|
| Reference Values | 15 | 2016 | 4919 | 0.270 |
Why?
|
| Apolipoproteins | 2 | 2023 | 326 | 0.270 |
Why?
|
| Vascular Diseases | 4 | 2020 | 1159 | 0.270 |
Why?
|
| Subcutaneous Fat | 8 | 2010 | 393 | 0.270 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2021 | 2252 | 0.260 |
Why?
|
| Mice, Obese | 8 | 2012 | 418 | 0.260 |
Why?
|
| Brain Ischemia | 4 | 2019 | 3030 | 0.260 |
Why?
|
| Leptin | 6 | 2006 | 1595 | 0.260 |
Why?
|
| Proteins | 6 | 2015 | 6030 | 0.260 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2021 | 144 | 0.260 |
Why?
|
| Foreign Bodies | 1 | 2010 | 402 | 0.260 |
Why?
|
| Rest | 2 | 2010 | 918 | 0.260 |
Why?
|
| Animals | 58 | 2021 | 168202 | 0.260 |
Why?
|
| Proteomics | 4 | 2024 | 3836 | 0.260 |
Why?
|
| Access to Information | 1 | 2009 | 316 | 0.250 |
Why?
|
| Blood Coagulation | 3 | 2019 | 1154 | 0.250 |
Why?
|
| Medical Informatics | 3 | 2019 | 732 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 7 | 2017 | 6473 | 0.250 |
Why?
|
| Radiography | 12 | 2016 | 6961 | 0.250 |
Why?
|
| Polysomnography | 6 | 2007 | 1852 | 0.250 |
Why?
|
| Body Fat Distribution | 4 | 2014 | 245 | 0.250 |
Why?
|
| Metabolism | 1 | 2007 | 193 | 0.250 |
Why?
|
| Fibromuscular Dysplasia | 2 | 2022 | 55 | 0.250 |
Why?
|
| Uric Acid | 3 | 2019 | 806 | 0.250 |
Why?
|
| Food | 1 | 2010 | 768 | 0.250 |
Why?
|
| Delta Rhythm | 1 | 2005 | 81 | 0.250 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2005 | 93 | 0.240 |
Why?
|
| Thrombolytic Therapy | 7 | 2005 | 2055 | 0.240 |
Why?
|
| Health Surveys | 6 | 2021 | 4036 | 0.240 |
Why?
|
| Receptors, LDL | 6 | 2022 | 488 | 0.240 |
Why?
|
| Diabetes Mellitus | 12 | 2018 | 5838 | 0.240 |
Why?
|
| Cross-Sectional Studies | 37 | 2022 | 26065 | 0.240 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 745 | 0.240 |
Why?
|
| Papillary Muscles | 2 | 2017 | 192 | 0.240 |
Why?
|
| Reproducibility of Results | 28 | 2018 | 20077 | 0.240 |
Why?
|
| Contrast Media | 2 | 2017 | 5305 | 0.240 |
Why?
|
| Urban Population | 3 | 2023 | 2034 | 0.230 |
Why?
|
| Erythrocytes | 5 | 2016 | 2410 | 0.230 |
Why?
|
| Artifacts | 3 | 2011 | 1910 | 0.230 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2021 | 1163 | 0.230 |
Why?
|
| Siblings | 2 | 2005 | 824 | 0.230 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2017 | 304 | 0.230 |
Why?
|
| Gene Expression | 11 | 2022 | 7569 | 0.230 |
Why?
|
| Receptors, Immunologic | 4 | 2017 | 1409 | 0.220 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2001 | 577 | 0.220 |
Why?
|
| Ankle Brachial Index | 4 | 2013 | 163 | 0.220 |
Why?
|
| Meta-Analysis as Topic | 8 | 2020 | 1380 | 0.220 |
Why?
|
| Antihypertensive Agents | 7 | 2021 | 2018 | 0.220 |
Why?
|
| Inflammation | 10 | 2023 | 10759 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2009 | 430 | 0.220 |
Why?
|
| Europe | 10 | 2022 | 3415 | 0.220 |
Why?
|
| Life Style | 5 | 2018 | 3907 | 0.220 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 426 | 0.220 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2020 | 3245 | 0.220 |
Why?
|
| Myocardium | 7 | 2014 | 4725 | 0.220 |
Why?
|
| Obesity, Abdominal | 3 | 2011 | 373 | 0.220 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2011 | 992 | 0.220 |
Why?
|
| Systems Biology | 4 | 2015 | 481 | 0.210 |
Why?
|
| Organ Size | 9 | 2014 | 2252 | 0.210 |
Why?
|
| Hospitalization | 7 | 2022 | 10708 | 0.210 |
Why?
|
| Ventricular Function, Right | 2 | 2018 | 617 | 0.210 |
Why?
|
| Ultrasonography | 12 | 2012 | 5965 | 0.210 |
Why?
|
| Morbidity | 6 | 2021 | 1750 | 0.210 |
Why?
|
| Exercise Test | 8 | 2012 | 2127 | 0.210 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 1866 | 0.210 |
Why?
|
| Genetic Research | 4 | 2011 | 171 | 0.210 |
Why?
|
| Cerebrovascular Disorders | 4 | 2017 | 1474 | 0.210 |
Why?
|
| Population Surveillance | 3 | 2005 | 2597 | 0.210 |
Why?
|
| Syntaxin 1 | 2 | 2014 | 29 | 0.210 |
Why?
|
| Erythropoiesis | 2 | 2016 | 684 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 4 | 2013 | 1086 | 0.200 |
Why?
|
| Fatty Liver | 4 | 2011 | 787 | 0.200 |
Why?
|
| Aortic Aneurysm | 3 | 2018 | 648 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 13 | 2014 | 4739 | 0.200 |
Why?
|
| Albuminuria | 4 | 2017 | 655 | 0.200 |
Why?
|
| Apolipoproteins A | 3 | 2014 | 95 | 0.200 |
Why?
|
| Hypertriglyceridemia | 3 | 2011 | 293 | 0.200 |
Why?
|
| Sex Distribution | 12 | 2013 | 2278 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 10 | 2020 | 2896 | 0.200 |
Why?
|
| Lung | 5 | 2015 | 9999 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2013 | 4058 | 0.200 |
Why?
|
| Sequence Analysis, RNA | 4 | 2021 | 2013 | 0.200 |
Why?
|
| Vasodilation | 3 | 2015 | 962 | 0.200 |
Why?
|
| Protein Phosphatase 1 | 2 | 2021 | 134 | 0.200 |
Why?
|
| Species Specificity | 4 | 2012 | 2410 | 0.200 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2015 | 1222 | 0.200 |
Why?
|
| Software | 5 | 2014 | 4432 | 0.200 |
Why?
|
| Age of Onset | 9 | 2016 | 3303 | 0.200 |
Why?
|
| Models, Genetic | 10 | 2019 | 3431 | 0.200 |
Why?
|
| Lipolysis | 2 | 2018 | 211 | 0.200 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2022 | 1228 | 0.200 |
Why?
|
| Electronic Health Records | 6 | 2022 | 4810 | 0.200 |
Why?
|
| Causality | 5 | 2021 | 1241 | 0.200 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2024 | 928 | 0.190 |
Why?
|
| Analysis of Variance | 10 | 2013 | 6223 | 0.190 |
Why?
|
| Telomere | 1 | 2008 | 942 | 0.190 |
Why?
|
| Vehicle Emissions | 2 | 2017 | 655 | 0.190 |
Why?
|
| Comorbidity | 15 | 2022 | 10507 | 0.190 |
Why?
|
| Lipid Metabolism | 5 | 2021 | 1896 | 0.190 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7873 | 0.190 |
Why?
|
| Liver Glycogen | 1 | 2021 | 35 | 0.190 |
Why?
|
| Adiponectin | 4 | 2012 | 1107 | 0.190 |
Why?
|
| Computational Biology | 7 | 2019 | 3509 | 0.190 |
Why?
|
| Information Dissemination | 3 | 2019 | 1126 | 0.180 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 41 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2021 | 773 | 0.180 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2021 | 488 | 0.180 |
Why?
|
| Interleukin-6 | 6 | 2009 | 3205 | 0.180 |
Why?
|
| Fasting | 4 | 2015 | 1603 | 0.180 |
Why?
|
| Body Size | 3 | 2014 | 463 | 0.180 |
Why?
|
| Data Interpretation, Statistical | 4 | 2019 | 2689 | 0.180 |
Why?
|
| Gene Expression Regulation | 15 | 2021 | 11874 | 0.180 |
Why?
|
| Larva | 2 | 2013 | 509 | 0.180 |
Why?
|
| Hypoglycemic Agents | 2 | 2020 | 3085 | 0.180 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2018 | 127 | 0.180 |
Why?
|
| Aspirin | 6 | 2011 | 3127 | 0.180 |
Why?
|
| Disease Progression | 13 | 2021 | 13495 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2023 | 831 | 0.180 |
Why?
|
| Age Distribution | 11 | 2013 | 2872 | 0.180 |
Why?
|
| Diethylstilbestrol | 1 | 2000 | 87 | 0.180 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1248 | 0.180 |
Why?
|
| Cystatin C | 4 | 2016 | 270 | 0.180 |
Why?
|
| Family Health | 7 | 2007 | 1253 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2013 | 789 | 0.170 |
Why?
|
| Magnesium | 2 | 2013 | 804 | 0.170 |
Why?
|
| Arousal | 2 | 2003 | 1171 | 0.170 |
Why?
|
| Brachial Artery | 4 | 2012 | 366 | 0.170 |
Why?
|
| Fibrinolysis | 2 | 2021 | 331 | 0.170 |
Why?
|
| Algorithms | 12 | 2019 | 14024 | 0.170 |
Why?
|
| DNA | 6 | 2020 | 7196 | 0.170 |
Why?
|
| Genes | 5 | 2014 | 1823 | 0.170 |
Why?
|
| Hospital Charges | 2 | 2021 | 350 | 0.170 |
Why?
|
| Hyperlipidemias | 5 | 2015 | 770 | 0.170 |
Why?
|
| Contact Lenses | 1 | 2001 | 138 | 0.170 |
Why?
|
| Veterans Health | 1 | 2021 | 215 | 0.160 |
Why?
|
| Random Allocation | 2 | 2017 | 2392 | 0.160 |
Why?
|
| Health Policy | 1 | 2012 | 2682 | 0.160 |
Why?
|
| Iopamidol | 2 | 2017 | 186 | 0.160 |
Why?
|
| Fibrinolytic Agents | 5 | 2012 | 2073 | 0.160 |
Why?
|
| Health Status Indicators | 2 | 2018 | 970 | 0.160 |
Why?
|
| Bundle-Branch Block | 2 | 2018 | 276 | 0.160 |
Why?
|
| Apolipoprotein C-III | 2 | 2014 | 210 | 0.160 |
Why?
|
| Platelet Function Tests | 2 | 2018 | 271 | 0.160 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2019 | 19 | 0.160 |
Why?
|
| Sweden | 2 | 2021 | 1379 | 0.160 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2019 | 550 | 0.160 |
Why?
|
| Public Health | 2 | 2012 | 2671 | 0.160 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2022 | 395 | 0.160 |
Why?
|
| Diastole | 8 | 2022 | 781 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2021 | 233 | 0.160 |
Why?
|
| Base Sequence | 6 | 2015 | 12420 | 0.160 |
Why?
|
| Leukocytosis | 1 | 2000 | 251 | 0.160 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 55 | 0.160 |
Why?
|
| DNA Mutational Analysis | 4 | 2016 | 4110 | 0.160 |
Why?
|
| Waist Circumference | 10 | 2012 | 933 | 0.160 |
Why?
|
| Models, Nursing | 1 | 2018 | 46 | 0.160 |
Why?
|
| Retrospective Studies | 25 | 2023 | 80583 | 0.160 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2018 | 85 | 0.160 |
Why?
|
| Genes, Neoplasm | 1 | 2020 | 370 | 0.160 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2000 | 344 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2012 | 4340 | 0.160 |
Why?
|
| Factor V | 3 | 2019 | 167 | 0.160 |
Why?
|
| Gout | 2 | 2019 | 621 | 0.150 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 5031 | 0.150 |
Why?
|
| Dietary Supplements | 5 | 2017 | 3412 | 0.150 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 149 | 0.150 |
Why?
|
| Self Disclosure | 1 | 1999 | 249 | 0.150 |
Why?
|
| Tetrazoles | 1 | 2024 | 909 | 0.150 |
Why?
|
| Independent Living | 2 | 2022 | 577 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2010 | 322 | 0.150 |
Why?
|
| Drug Combinations | 1 | 2024 | 2048 | 0.150 |
Why?
|
| Vitamin K 1 | 2 | 2008 | 47 | 0.150 |
Why?
|
| Victoria | 3 | 2013 | 64 | 0.150 |
Why?
|
| Alkaline Phosphatase | 1 | 2021 | 860 | 0.150 |
Why?
|
| Inservice Training | 1 | 2000 | 375 | 0.150 |
Why?
|
| Homocysteine | 2 | 2013 | 637 | 0.150 |
Why?
|
| Thorax | 3 | 2017 | 555 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2019 | 224 | 0.150 |
Why?
|
| Receptors, Cell Surface | 4 | 2013 | 2802 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2023 | 2200 | 0.150 |
Why?
|
| Research Design | 5 | 2014 | 6174 | 0.150 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2004 | 363 | 0.150 |
Why?
|
| Creatine Kinase | 1 | 1999 | 685 | 0.150 |
Why?
|
| Lipase | 5 | 2022 | 324 | 0.150 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2013 | 412 | 0.140 |
Why?
|
| Kidney Diseases | 4 | 2017 | 2090 | 0.140 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2017 | 33 | 0.140 |
Why?
|
| Universities | 1 | 2023 | 994 | 0.140 |
Why?
|
| Chromosomes, Human | 4 | 2013 | 441 | 0.140 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2020 | 307 | 0.140 |
Why?
|
| ABO Blood-Group System | 2 | 2020 | 380 | 0.140 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2017 | 78 | 0.140 |
Why?
|
| Sex Characteristics | 6 | 2022 | 2637 | 0.140 |
Why?
|
| Neck | 2 | 2013 | 734 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 131 | 0.140 |
Why?
|
| Cooking | 1 | 2019 | 309 | 0.140 |
Why?
|
| Signal Transduction | 7 | 2019 | 23415 | 0.140 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 540 | 0.140 |
Why?
|
| Young Adult | 16 | 2023 | 59191 | 0.140 |
Why?
|
| Respiratory Mechanics | 4 | 2005 | 699 | 0.140 |
Why?
|
| Exocytosis | 2 | 2016 | 320 | 0.140 |
Why?
|
| Genetics, Medical | 2 | 2011 | 334 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2012 | 10429 | 0.140 |
Why?
|
| Creatinine | 6 | 2021 | 1895 | 0.140 |
Why?
|
| Testosterone | 2 | 2019 | 2472 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2013 | 3356 | 0.140 |
Why?
|
| Blood Cell Count | 3 | 2016 | 397 | 0.140 |
Why?
|
| Glucose | 4 | 2012 | 4345 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 471 | 0.130 |
Why?
|
| Tropomyosin | 1 | 2016 | 104 | 0.130 |
Why?
|
| Body Surface Area | 2 | 2016 | 197 | 0.130 |
Why?
|
| Corticosterone | 2 | 2007 | 305 | 0.130 |
Why?
|
| Alzheimer Disease | 6 | 2021 | 8603 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2020 | 3394 | 0.130 |
Why?
|
| Pedigree | 6 | 2012 | 4539 | 0.130 |
Why?
|
| RNA, Messenger | 10 | 2015 | 12759 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2569 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2017 | 527 | 0.130 |
Why?
|
| Leukoaraiosis | 1 | 2017 | 116 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2208 | 0.130 |
Why?
|
| Entomology | 2 | 2013 | 7 | 0.130 |
Why?
|
| Hemodynamics | 4 | 2014 | 4160 | 0.130 |
Why?
|
| Endothelial Cells | 6 | 2017 | 3550 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 429 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2022 | 2872 | 0.130 |
Why?
|
| Hemoperitoneum | 1 | 2015 | 38 | 0.130 |
Why?
|
| Drosophila Proteins | 2 | 2016 | 1698 | 0.130 |
Why?
|
| Automobiles | 1 | 2016 | 111 | 0.130 |
Why?
|
| Postmortem Changes | 2 | 2013 | 119 | 0.130 |
Why?
|
| Isocitrates | 1 | 2015 | 23 | 0.130 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 1034 | 0.130 |
Why?
|
| Vitamins | 3 | 2009 | 1635 | 0.130 |
Why?
|
| Taurocholic Acid | 1 | 2015 | 43 | 0.130 |
Why?
|
| Mutation, Missense | 7 | 2021 | 2570 | 0.130 |
Why?
|
| Chemokine CCL2 | 3 | 2007 | 602 | 0.130 |
Why?
|
| Chi-Square Distribution | 6 | 2017 | 3410 | 0.120 |
Why?
|
| Body Weight | 6 | 2010 | 4615 | 0.120 |
Why?
|
| Pulsatile Flow | 2 | 2014 | 320 | 0.120 |
Why?
|
| Lumbar Vertebrae | 4 | 2010 | 1874 | 0.120 |
Why?
|
| Nursing Staff, Hospital | 1 | 2018 | 348 | 0.120 |
Why?
|
| Home Childbirth | 1 | 2015 | 54 | 0.120 |
Why?
|
| Patient Selection | 4 | 2009 | 4237 | 0.120 |
Why?
|
| Hyoid Bone | 1 | 2015 | 38 | 0.120 |
Why?
|
| Hematopoiesis | 2 | 2016 | 2049 | 0.120 |
Why?
|
| Hypercapnia | 2 | 2008 | 261 | 0.120 |
Why?
|
| Exons | 4 | 2015 | 2381 | 0.120 |
Why?
|
| Estrone | 1 | 2016 | 234 | 0.120 |
Why?
|
| Heparin | 3 | 2000 | 1632 | 0.120 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 283 | 0.120 |
Why?
|
| Phospholipase D | 1 | 2015 | 67 | 0.120 |
Why?
|
| Osteoprotegerin | 3 | 2010 | 176 | 0.120 |
Why?
|
| Managed Care Programs | 1 | 2000 | 937 | 0.120 |
Why?
|
| Asymptomatic Diseases | 2 | 2016 | 587 | 0.120 |
Why?
|
| Particulate Matter | 2 | 2017 | 2602 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 748 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 520 | 0.120 |
Why?
|
| Drug Design | 2 | 2010 | 1045 | 0.120 |
Why?
|
| Advisory Committees | 2 | 2009 | 787 | 0.120 |
Why?
|
| Parents | 6 | 2014 | 3563 | 0.120 |
Why?
|
| Disease-Free Survival | 4 | 2017 | 6807 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 611 | 0.120 |
Why?
|
| Anticholesteremic Agents | 1 | 2021 | 967 | 0.120 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2000 | 1191 | 0.120 |
Why?
|
| Cardiac Output, Low | 1 | 2015 | 191 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2016 | 2327 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 2 | 2011 | 583 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2000 | 718 | 0.110 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2016 | 180 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2020 | 1186 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 2 | 2008 | 414 | 0.110 |
Why?
|
| Mice, Knockout | 6 | 2019 | 14388 | 0.110 |
Why?
|
| Triage | 1 | 2021 | 984 | 0.110 |
Why?
|
| Natural Language Processing | 2 | 2019 | 1166 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 933 | 0.110 |
Why?
|
| Immune System Diseases | 1 | 2016 | 254 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 912 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 210 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 5334 | 0.110 |
Why?
|
| Computer Simulation | 3 | 2013 | 6233 | 0.110 |
Why?
|
| Mutation | 11 | 2020 | 30015 | 0.110 |
Why?
|
| SOX Transcription Factors | 1 | 2013 | 7 | 0.110 |
Why?
|
| Decision Support Techniques | 3 | 2019 | 1999 | 0.110 |
Why?
|
| Pseudogenes | 1 | 2013 | 104 | 0.110 |
Why?
|
| Publishing | 2 | 2011 | 832 | 0.110 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2013 | 32 | 0.110 |
Why?
|
| Gene Silencing | 3 | 2014 | 1503 | 0.110 |
Why?
|
| Tracheobronchomalacia | 1 | 2015 | 131 | 0.110 |
Why?
|
| Observer Variation | 7 | 2012 | 2607 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2019 | 1594 | 0.110 |
Why?
|
| Electroencephalography | 3 | 2009 | 6240 | 0.110 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 4028 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 3527 | 0.110 |
Why?
|
| Pulmonary Emphysema | 2 | 2016 | 684 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2013 | 4937 | 0.110 |
Why?
|
| Hyperglycemia | 3 | 2009 | 1375 | 0.110 |
Why?
|
| Thyroid Cartilage | 1 | 2013 | 43 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 5 | 2015 | 7390 | 0.110 |
Why?
|
| SOXD Transcription Factors | 1 | 2013 | 44 | 0.110 |
Why?
|
| Sleep | 3 | 2003 | 4764 | 0.110 |
Why?
|
| Severity of Illness Index | 12 | 2017 | 15829 | 0.110 |
Why?
|
| Cell Line | 11 | 2019 | 15577 | 0.110 |
Why?
|
| Hematocrit | 3 | 2016 | 623 | 0.110 |
Why?
|
| Amino Acids | 2 | 2017 | 1718 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2023 | 12116 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2007 | 705 | 0.110 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2012 | 39 | 0.110 |
Why?
|
| Genetics | 1 | 2013 | 114 | 0.110 |
Why?
|
| Survival Rate | 10 | 2012 | 12719 | 0.110 |
Why?
|
| Plasma | 1 | 2016 | 586 | 0.110 |
Why?
|
| Prescription Drugs | 1 | 2020 | 631 | 0.100 |
Why?
|
| Disease Models, Animal | 9 | 2016 | 18220 | 0.100 |
Why?
|
| Diptera | 1 | 2013 | 50 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 2009 | 1463 | 0.100 |
Why?
|
| Organ Specificity | 4 | 2021 | 1964 | 0.100 |
Why?
|
| Myiasis | 1 | 2012 | 14 | 0.100 |
Why?
|
| DNA, Recombinant | 1 | 2013 | 455 | 0.100 |
Why?
|
| Microarray Analysis | 3 | 2016 | 748 | 0.100 |
Why?
|
| Endothelium, Vascular | 4 | 2011 | 4433 | 0.100 |
Why?
|
| Mice, Inbred C3H | 2 | 2004 | 913 | 0.100 |
Why?
|
| Exercise | 3 | 2018 | 5886 | 0.100 |
Why?
|
| Cause of Death | 5 | 2017 | 3683 | 0.100 |
Why?
|
| Resistin | 2 | 2012 | 172 | 0.100 |
Why?
|
| Forensic Sciences | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2012 | 53 | 0.100 |
Why?
|
| Microsatellite Repeats | 3 | 2009 | 783 | 0.100 |
Why?
|
| ROC Curve | 5 | 2019 | 3575 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 361 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2000 | 1389 | 0.100 |
Why?
|
| Disease | 2 | 2015 | 670 | 0.100 |
Why?
|
| Renal Artery | 1 | 2013 | 351 | 0.100 |
Why?
|
| Postpartum Hemorrhage | 1 | 2015 | 272 | 0.100 |
Why?
|
| P-Selectin | 3 | 2014 | 599 | 0.100 |
Why?
|
| Sarcomeres | 2 | 2012 | 369 | 0.100 |
Why?
|
| Endothelium | 1 | 2014 | 764 | 0.100 |
Why?
|
| Length of Stay | 3 | 2021 | 6418 | 0.100 |
Why?
|
| Rural Population | 2 | 2020 | 2277 | 0.100 |
Why?
|
| Captopril | 1 | 2012 | 265 | 0.100 |
Why?
|
| Fibrinogens, Abnormal | 1 | 2011 | 10 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2016 | 743 | 0.100 |
Why?
|
| Neck Injuries | 1 | 2013 | 160 | 0.100 |
Why?
|
| Sterol Esterase | 1 | 2011 | 40 | 0.100 |
Why?
|
| Nutritional Status | 2 | 2011 | 1597 | 0.090 |
Why?
|
| Mortality | 3 | 2020 | 2899 | 0.090 |
Why?
|
| Housing | 1 | 2016 | 669 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2012 | 1310 | 0.090 |
Why?
|
| Phospholipids | 2 | 2012 | 787 | 0.090 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2012 | 144 | 0.090 |
Why?
|
| Models, Statistical | 5 | 2017 | 5074 | 0.090 |
Why?
|
| Health Records, Personal | 1 | 2012 | 127 | 0.090 |
Why?
|
| Forensic Medicine | 1 | 2011 | 64 | 0.090 |
Why?
|
| Chronic Disease | 6 | 2012 | 9310 | 0.090 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2013 | 557 | 0.090 |
Why?
|
| Database Management Systems | 1 | 2012 | 257 | 0.090 |
Why?
|
| RNA | 2 | 2014 | 2713 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 699 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1857 | 0.090 |
Why?
|
| Acute Disease | 3 | 2012 | 7236 | 0.090 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2010 | 42 | 0.090 |
Why?
|
| Observation | 2 | 2005 | 310 | 0.090 |
Why?
|
| MicroRNAs | 3 | 2017 | 3802 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2010 | 55 | 0.090 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2015 | 339 | 0.090 |
Why?
|
| DNA-Binding Proteins | 6 | 2019 | 9586 | 0.090 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 547 | 0.090 |
Why?
|
| Mice, Transgenic | 4 | 2016 | 9526 | 0.090 |
Why?
|
| Resuscitation | 1 | 2015 | 672 | 0.090 |
Why?
|
| Sphingolipids | 1 | 2012 | 173 | 0.090 |
Why?
|
| Epiglottis | 1 | 2010 | 81 | 0.090 |
Why?
|
| Forensic Dentistry | 1 | 2009 | 3 | 0.090 |
Why?
|
| Age Determination by Teeth | 1 | 2009 | 10 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2012 | 393 | 0.090 |
Why?
|
| Antigens, Human Platelet | 2 | 2001 | 41 | 0.090 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 350 | 0.090 |
Why?
|
| Base Pairing | 1 | 2010 | 140 | 0.090 |
Why?
|
| Natriuretic Peptides | 1 | 2011 | 155 | 0.090 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.090 |
Why?
|
| Food Handling | 1 | 2010 | 154 | 0.090 |
Why?
|
| Enzymes | 1 | 2011 | 257 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3607 | 0.090 |
Why?
|
| Radiography, Dental | 1 | 2009 | 54 | 0.090 |
Why?
|
| Echocardiography | 6 | 2011 | 4987 | 0.090 |
Why?
|
| Proinsulin | 1 | 2010 | 135 | 0.090 |
Why?
|
| Survival Analysis | 8 | 2015 | 10072 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2015 | 697 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 5789 | 0.080 |
Why?
|
| Bone Density | 3 | 2015 | 3548 | 0.080 |
Why?
|
| Calcium, Dietary | 1 | 2012 | 529 | 0.080 |
Why?
|
| Adenosine Diphosphate | 4 | 2010 | 422 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 123 | 0.080 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 341 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2014 | 734 | 0.080 |
Why?
|
| Chromatin | 2 | 2022 | 2955 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1923 | 0.080 |
Why?
|
| Microfilament Proteins | 4 | 2020 | 1130 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2019 | 174 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2011 | 10203 | 0.080 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2010 | 186 | 0.080 |
Why?
|
| Blood Vessels | 2 | 2007 | 1112 | 0.080 |
Why?
|
| Pharynx | 2 | 2010 | 432 | 0.080 |
Why?
|
| Ventricular Dysfunction | 1 | 2010 | 144 | 0.080 |
Why?
|
| Regression Analysis | 8 | 2014 | 6339 | 0.080 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2092 | 0.080 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2010 | 108 | 0.080 |
Why?
|
| Central Nervous System Depressants | 1 | 2010 | 164 | 0.080 |
Why?
|
| Thromboplastin | 1 | 2011 | 286 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 988 | 0.080 |
Why?
|
| DNA Primers | 2 | 2014 | 2817 | 0.080 |
Why?
|
| Heart Function Tests | 1 | 2010 | 318 | 0.080 |
Why?
|
| Platelet Activation | 2 | 2016 | 646 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2017 | 1834 | 0.080 |
Why?
|
| Arcus Senilis | 1 | 2008 | 4 | 0.080 |
Why?
|
| Sensitivity and Specificity | 8 | 2014 | 14649 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1992 | 888 | 0.080 |
Why?
|
| Adolescent | 17 | 2019 | 88247 | 0.080 |
Why?
|
| Blood | 1 | 2011 | 596 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 2 | 2013 | 994 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3798 | 0.080 |
Why?
|
| Body Composition | 3 | 2010 | 2426 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 3204 | 0.080 |
Why?
|
| Estradiol | 1 | 2016 | 1937 | 0.080 |
Why?
|
| Intention | 1 | 2011 | 346 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1505 | 0.080 |
Why?
|
| Interleukins | 1 | 2013 | 783 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2009 | 242 | 0.080 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 603 | 0.080 |
Why?
|
| Disease Susceptibility | 4 | 2007 | 1788 | 0.080 |
Why?
|
| Heterozygote | 4 | 2018 | 2780 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 482 | 0.080 |
Why?
|
| Organic Anion Transporters | 1 | 2009 | 101 | 0.080 |
Why?
|
| Microglia | 1 | 2017 | 1357 | 0.080 |
Why?
|
| CD40 Ligand | 2 | 2007 | 521 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2010 | 318 | 0.080 |
Why?
|
| Arachnodactyly | 1 | 2008 | 10 | 0.080 |
Why?
|
| Disclosure | 2 | 2011 | 747 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2017 | 1851 | 0.080 |
Why?
|
| Spine | 1 | 2015 | 1112 | 0.080 |
Why?
|
| Angiography | 1 | 2013 | 1595 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2009 | 158 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 4512 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 1790 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2010 | 898 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2009 | 346 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2000 | 2518 | 0.070 |
Why?
|
| Oxyhemoglobins | 1 | 2008 | 212 | 0.070 |
Why?
|
| Stem Cells | 2 | 2011 | 3514 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1890 | 0.070 |
Why?
|
| Troponin T | 1 | 2012 | 780 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2011 | 277 | 0.070 |
Why?
|
| Propranolol | 1 | 2009 | 490 | 0.070 |
Why?
|
| Prediabetic State | 1 | 2013 | 545 | 0.070 |
Why?
|
| Mouth | 1 | 2010 | 381 | 0.070 |
Why?
|
| Family | 3 | 2009 | 3193 | 0.070 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2017 | 1400 | 0.070 |
Why?
|
| Communication | 1 | 2022 | 3851 | 0.070 |
Why?
|
| Anthropometry | 4 | 2016 | 1338 | 0.070 |
Why?
|
| Cardiac Output | 1 | 2010 | 831 | 0.070 |
Why?
|
| Cluster Analysis | 4 | 2017 | 2703 | 0.070 |
Why?
|
| Longevity | 1 | 2015 | 1064 | 0.070 |
Why?
|
| Epinephrine | 4 | 2010 | 792 | 0.070 |
Why?
|
| Multigene Family | 2 | 2011 | 1076 | 0.070 |
Why?
|
| Collagen | 4 | 2010 | 2634 | 0.070 |
Why?
|
| Skull | 1 | 2012 | 818 | 0.070 |
Why?
|
| Hemangioma | 1 | 2012 | 727 | 0.070 |
Why?
|
| Societies, Nursing | 1 | 2006 | 22 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 6188 | 0.070 |
Why?
|
| Checklist | 2 | 2011 | 827 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 1997 | 2746 | 0.070 |
Why?
|
| Osteocalcin | 1 | 2007 | 274 | 0.070 |
Why?
|
| Brain | 6 | 2017 | 27100 | 0.070 |
Why?
|
| Alcoholism | 1 | 2018 | 1972 | 0.070 |
Why?
|
| Limbus Corneae | 1 | 2008 | 143 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 933 | 0.070 |
Why?
|
| Macular Degeneration | 1 | 2014 | 1008 | 0.070 |
Why?
|
| Zygapophyseal Joint | 1 | 2008 | 127 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 1624 | 0.070 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2007 | 148 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 2013 | 704 | 0.070 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 359 | 0.070 |
Why?
|
| Drug Approval | 2 | 2010 | 812 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4569 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2019 | 126 | 0.070 |
Why?
|
| Respiration, Artificial | 4 | 2005 | 2630 | 0.070 |
Why?
|
| Platelet Count | 3 | 2016 | 780 | 0.070 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 2006 | 36 | 0.070 |
Why?
|
| Cystatins | 2 | 2021 | 55 | 0.070 |
Why?
|
| Diterpenes | 2 | 1984 | 170 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3688 | 0.070 |
Why?
|
| Glucose Clamp Technique | 1 | 2007 | 262 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2009 | 400 | 0.070 |
Why?
|
| Placenta | 1 | 2015 | 1709 | 0.070 |
Why?
|
| Lymphocytes | 2 | 2011 | 2604 | 0.070 |
Why?
|
| Area Under Curve | 3 | 2019 | 1635 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2007 | 1128 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2018 | 4392 | 0.070 |
Why?
|
| Exostoses | 1 | 2006 | 30 | 0.070 |
Why?
|
| Death, Sudden | 1 | 2008 | 301 | 0.060 |
Why?
|
| Overweight | 2 | 2007 | 2417 | 0.060 |
Why?
|
| Environmental Exposure | 2 | 2016 | 4483 | 0.060 |
Why?
|
| Marfan Syndrome | 1 | 2008 | 236 | 0.060 |
Why?
|
| Heparitin Sulfate | 1 | 2007 | 223 | 0.060 |
Why?
|
| Chemokines | 1 | 2010 | 954 | 0.060 |
Why?
|
| Plasminogen Activators | 1 | 2006 | 199 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 2 | 2016 | 2917 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 271 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2006 | 174 | 0.060 |
Why?
|
| Receptors, Chemokine | 2 | 2013 | 652 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2021 | 3801 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2013 | 1739 | 0.060 |
Why?
|
| Neoplasms | 4 | 2020 | 22131 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2010 | 597 | 0.060 |
Why?
|
| Drosophila | 1 | 2013 | 1494 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 1300 | 0.060 |
Why?
|
| Aging, Premature | 1 | 2005 | 44 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1517 | 0.060 |
Why?
|
| Larynx | 1 | 2010 | 492 | 0.060 |
Why?
|
| Air Pollutants | 2 | 2017 | 2893 | 0.060 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 1 | 2005 | 24 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2011 | 1566 | 0.060 |
Why?
|
| Quality Control | 2 | 2020 | 831 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 2 | 2019 | 997 | 0.060 |
Why?
|
| Sample Size | 2 | 2022 | 838 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2020 | 7963 | 0.060 |
Why?
|
| Population Groups | 2 | 2021 | 207 | 0.060 |
Why?
|
| Osteoporotic Fractures | 1 | 2010 | 410 | 0.060 |
Why?
|
| Genetics, Population | 3 | 2018 | 935 | 0.060 |
Why?
|
| Confidence Intervals | 4 | 2010 | 2925 | 0.060 |
Why?
|
| Muridae | 1 | 2004 | 56 | 0.060 |
Why?
|
| Alanine | 1 | 2008 | 609 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3045 | 0.060 |
Why?
|
| Brain Infarction | 1 | 2007 | 289 | 0.060 |
Why?
|
| Models, Animal | 3 | 2010 | 2108 | 0.060 |
Why?
|
| Isoproterenol | 2 | 1984 | 397 | 0.060 |
Why?
|
| Cyclins | 1 | 2007 | 594 | 0.060 |
Why?
|
| Emergency Medical Services | 2 | 2015 | 1921 | 0.060 |
Why?
|
| Renin | 1 | 2007 | 640 | 0.060 |
Why?
|
| Psychotropic Drugs | 1 | 2010 | 888 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2005 | 186 | 0.060 |
Why?
|
| Up-Regulation | 4 | 2018 | 4117 | 0.060 |
Why?
|
| Cells, Cultured | 6 | 2018 | 18937 | 0.060 |
Why?
|
| Death Certificates | 1 | 2005 | 167 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1217 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2006 | 340 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2008 | 1148 | 0.060 |
Why?
|
| Monocytes | 4 | 2017 | 2565 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 1780 | 0.060 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2004 | 224 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2020 | 0.060 |
Why?
|
| Mass Spectrometry | 3 | 2017 | 2189 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17630 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 1320 | 0.060 |
Why?
|
| Autonomic Nervous System | 2 | 2007 | 704 | 0.060 |
Why?
|
| Genetic Code | 2 | 2014 | 137 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2015 | 26183 | 0.060 |
Why?
|
| Apolipoprotein E2 | 2 | 2016 | 135 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2012 | 1061 | 0.060 |
Why?
|
| Cadaver | 1 | 2008 | 1358 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2445 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2005 | 367 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2011 | 2764 | 0.060 |
Why?
|
| Informed Consent | 1 | 2010 | 1007 | 0.050 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 368 | 0.050 |
Why?
|
| Eating | 2 | 2007 | 1535 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1241 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2007 | 543 | 0.050 |
Why?
|
| Potassium Channels | 2 | 2017 | 537 | 0.050 |
Why?
|
| Premature Birth | 1 | 2015 | 1782 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 2409 | 0.050 |
Why?
|
| Spinal Fractures | 1 | 2010 | 704 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2812 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8652 | 0.050 |
Why?
|
| MEDLINE | 1 | 2003 | 119 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2015 | 3418 | 0.050 |
Why?
|
| Abdomen | 3 | 2020 | 1128 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2008 | 980 | 0.050 |
Why?
|
| Outpatients | 1 | 2011 | 1596 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2007 | 497 | 0.050 |
Why?
|
| Kinetocardiography | 1 | 2002 | 6 | 0.050 |
Why?
|
| Hemoglobins | 3 | 2016 | 1524 | 0.050 |
Why?
|
| Erythrocyte Indices | 2 | 2016 | 144 | 0.050 |
Why?
|
| Databases, Bibliographic | 1 | 2003 | 130 | 0.050 |
Why?
|
| Air Pollution | 1 | 2017 | 2355 | 0.050 |
Why?
|
| Inspiratory Capacity | 1 | 2002 | 35 | 0.050 |
Why?
|
| Metabolomics | 3 | 2017 | 1656 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1302 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 1927 | 0.050 |
Why?
|
| Aptamers, Nucleotide | 1 | 2024 | 164 | 0.050 |
Why?
|
| Chlamydophila Infections | 1 | 2002 | 23 | 0.050 |
Why?
|
| Bradycardia | 1 | 2004 | 299 | 0.050 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2002 | 53 | 0.050 |
Why?
|
| Internet | 4 | 2021 | 3094 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 2004 | 446 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2015 | 42193 | 0.050 |
Why?
|
| Cardiology | 1 | 2013 | 1656 | 0.050 |
Why?
|
| Hyperoxia | 1 | 2004 | 258 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 4947 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2003 | 310 | 0.050 |
Why?
|
| Oxidative Stress | 3 | 2009 | 3115 | 0.050 |
Why?
|
| Treatment Outcome | 12 | 2016 | 64572 | 0.050 |
Why?
|
| Baltimore | 1 | 2002 | 231 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2017 | 790 | 0.050 |
Why?
|
| Mice, Inbred CBA | 1 | 2002 | 436 | 0.050 |
Why?
|
| Introns | 3 | 2011 | 968 | 0.050 |
Why?
|
| Africa | 2 | 2016 | 714 | 0.050 |
Why?
|
| Angiotensin II | 2 | 2015 | 849 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 943 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 767 | 0.050 |
Why?
|
| Aldosterone | 1 | 2007 | 869 | 0.050 |
Why?
|
| Muscle Proteins | 3 | 2017 | 1152 | 0.050 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 2001 | 14 | 0.050 |
Why?
|
| Mitral Valve Stenosis | 1 | 2004 | 341 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2019 | 8619 | 0.050 |
Why?
|
| Sleep Stages | 1 | 2005 | 695 | 0.050 |
Why?
|
| Bacterial Toxins | 2 | 1984 | 925 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2007 | 739 | 0.050 |
Why?
|
| Interleukin-10 Receptor beta Subunit | 1 | 2021 | 15 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2002 | 273 | 0.050 |
Why?
|
| Pregnancy | 4 | 2016 | 29869 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2002 | 361 | 0.050 |
Why?
|
| Streptokinase | 3 | 1995 | 186 | 0.050 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2021 | 44 | 0.050 |
Why?
|
| Self Report | 3 | 2019 | 3727 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 18 | 0.050 |
Why?
|
| International Cooperation | 3 | 2018 | 1422 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2001 | 193 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 49 | 0.050 |
Why?
|
| Oxazolidinones | 1 | 2021 | 98 | 0.050 |
Why?
|
| Myosin Heavy Chains | 2 | 2019 | 404 | 0.050 |
Why?
|
| Emphysema | 1 | 2003 | 238 | 0.050 |
Why?
|
| Manometry | 2 | 2014 | 453 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7583 | 0.050 |
Why?
|
| Guideline Adherence | 2 | 2017 | 2218 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 2008 | 1063 | 0.040 |
Why?
|
| Lysophospholipase | 1 | 2020 | 66 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2021 | 110 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2020 | 56 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2003 | 387 | 0.040 |
Why?
|
| Esters | 1 | 2021 | 211 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2014 | 4269 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2003 | 590 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2012 | 1369 | 0.040 |
Why?
|
| Suicide | 1 | 2011 | 1601 | 0.040 |
Why?
|
| Hand | 1 | 2006 | 902 | 0.040 |
Why?
|
| Physicians | 2 | 2005 | 4583 | 0.040 |
Why?
|
| Dementia | 1 | 2015 | 2686 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 10754 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2008 | 982 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 301 | 0.040 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2009 | 276 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 1388 | 0.040 |
Why?
|
| Myosin Type V | 1 | 2019 | 32 | 0.040 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2019 | 59 | 0.040 |
Why?
|
| Cyclin D2 | 2 | 2012 | 98 | 0.040 |
Why?
|
| Education | 2 | 2014 | 534 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1662 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2017 | 2916 | 0.040 |
Why?
|
| Unified Medical Language System | 1 | 2019 | 89 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11512 | 0.040 |
Why?
|
| Point Mutation | 1 | 2004 | 1595 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 382 | 0.040 |
Why?
|
| Oxygen | 3 | 2004 | 4226 | 0.040 |
Why?
|
| Vasodilator Agents | 2 | 2015 | 973 | 0.040 |
Why?
|
| Homozygote | 4 | 2009 | 1776 | 0.040 |
Why?
|
| Probability | 3 | 2011 | 2475 | 0.040 |
Why?
|
| Terrorism | 1 | 2002 | 210 | 0.040 |
Why?
|
| Translations | 1 | 2019 | 81 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 1007 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2002 | 381 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2000 | 418 | 0.040 |
Why?
|
| Hip Fractures | 1 | 2007 | 988 | 0.040 |
Why?
|
| Blood Pressure Determination | 2 | 2000 | 633 | 0.040 |
Why?
|
| Queensland | 1 | 2018 | 52 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2013 | 410 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2002 | 391 | 0.040 |
Why?
|
| Medical Records | 1 | 2004 | 1408 | 0.040 |
Why?
|
| Erythrocyte Count | 2 | 2010 | 157 | 0.040 |
Why?
|
| Amides | 1 | 2021 | 449 | 0.040 |
Why?
|
| Chloroquine | 1 | 2020 | 275 | 0.040 |
Why?
|
| Child | 10 | 2015 | 80089 | 0.040 |
Why?
|
| Nose | 1 | 2002 | 521 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2005 | 847 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2003 | 638 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 1333 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 665 | 0.040 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2001 | 269 | 0.040 |
Why?
|
| Netherlands | 2 | 2016 | 2222 | 0.040 |
Why?
|
| Hypotension | 1 | 2004 | 879 | 0.040 |
Why?
|
| Patient Care | 1 | 2004 | 621 | 0.040 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 235 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 321 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2019 | 189 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 13383 | 0.040 |
Why?
|
| Waist-Hip Ratio | 2 | 2012 | 518 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 285 | 0.040 |
Why?
|
| Syndrome | 3 | 2011 | 3268 | 0.040 |
Why?
|
| Sodium Channels | 2 | 2010 | 339 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2000 | 6305 | 0.040 |
Why?
|
| Current Procedural Terminology | 1 | 2018 | 89 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2013 | 813 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 2894 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 8998 | 0.040 |
Why?
|
| Temperature | 1 | 2004 | 2224 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 4671 | 0.040 |
Why?
|
| Cholesterol Esters | 2 | 2013 | 73 | 0.040 |
Why?
|
| Health Maintenance Organizations | 1 | 2000 | 658 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2024 | 1040 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2007 | 1937 | 0.040 |
Why?
|
| Diet | 3 | 2013 | 8049 | 0.040 |
Why?
|
| omega-N-Methylarginine | 1 | 2017 | 108 | 0.040 |
Why?
|
| Chromosomes | 1 | 2020 | 578 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 319 | 0.040 |
Why?
|
| RGS Proteins | 1 | 2017 | 74 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2002 | 913 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2018 | 385 | 0.030 |
Why?
|
| Boston | 2 | 2000 | 9313 | 0.030 |
Why?
|
| Models, Biological | 3 | 2008 | 9461 | 0.030 |
Why?
|
| Femoral Artery | 2 | 2014 | 826 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2018 | 449 | 0.030 |
Why?
|
| Wakefulness | 1 | 2003 | 1264 | 0.030 |
Why?
|
| Iceland | 1 | 2016 | 184 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2016 | 85 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2017 | 90 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2021 | 3743 | 0.030 |
Why?
|
| Homeostasis | 4 | 2013 | 3321 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1169 | 0.030 |
Why?
|
| Trachea | 1 | 2002 | 1089 | 0.030 |
Why?
|
| Cytokines | 2 | 2008 | 7373 | 0.030 |
Why?
|
| Xanthines | 1 | 2016 | 120 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 2016 | 79 | 0.030 |
Why?
|
| Metagenomics | 1 | 2020 | 463 | 0.030 |
Why?
|
| Histidine | 1 | 2017 | 308 | 0.030 |
Why?
|
| Information Services | 1 | 2017 | 236 | 0.030 |
Why?
|
| Alcoholic Beverages | 1 | 2018 | 264 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 604 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2016 | 157 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
| Allelic Imbalance | 1 | 2016 | 77 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2002 | 827 | 0.030 |
Why?
|
| Kidney Function Tests | 2 | 2010 | 677 | 0.030 |
Why?
|
| Quinolines | 1 | 2021 | 764 | 0.030 |
Why?
|
| Heart Valves | 1 | 2017 | 284 | 0.030 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2006 | 85 | 0.030 |
Why?
|
| France | 1 | 2017 | 492 | 0.030 |
Why?
|
| Hirudin Therapy | 1 | 1995 | 43 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2011 | 1878 | 0.030 |
Why?
|
| Sex Determination by Skeleton | 1 | 2015 | 2 | 0.030 |
Why?
|
| Forensic Anthropology | 1 | 2015 | 8 | 0.030 |
Why?
|
| beta Carotene | 1 | 1997 | 523 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2021 | 1133 | 0.030 |
Why?
|
| Research | 2 | 2006 | 1977 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2002 | 1265 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2007 | 2214 | 0.030 |
Why?
|
| Respiratory System | 1 | 1998 | 563 | 0.030 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 354 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 166 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 72 | 0.030 |
Why?
|
| Physician's Role | 1 | 2002 | 917 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2010 | 6826 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2020 | 803 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2017 | 491 | 0.030 |
Why?
|
| Ireland | 1 | 2015 | 170 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6370 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1999 | 1687 | 0.030 |
Why?
|
| Cough | 1 | 1999 | 595 | 0.030 |
Why?
|
| Absorptiometry, Photon | 2 | 2017 | 1738 | 0.030 |
Why?
|
| Exhalation | 1 | 2015 | 181 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2014 | 3 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 223 | 0.030 |
Why?
|
| Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
| Transfection | 2 | 2014 | 5765 | 0.030 |
Why?
|
| Qa-SNARE Proteins | 1 | 2014 | 52 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2006 | 12966 | 0.030 |
Why?
|
| Cell Size | 2 | 2007 | 624 | 0.030 |
Why?
|
| Prehypertension | 1 | 2015 | 63 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 2015 | 202 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 265 | 0.030 |
Why?
|
| Seafood | 1 | 1998 | 393 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2015 | 200 | 0.030 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2014 | 22 | 0.030 |
Why?
|
| Age Determination by Skeleton | 1 | 2015 | 126 | 0.030 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 103 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 1754 | 0.030 |
Why?
|
| Mexican Americans | 1 | 1995 | 163 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2270 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 661 | 0.030 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2014 | 42 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2015 | 395 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2001 | 767 | 0.030 |
Why?
|
| Trust | 1 | 2019 | 529 | 0.030 |
Why?
|
| Texas | 1 | 1995 | 403 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2659 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2019 | 944 | 0.030 |
Why?
|
| Myocytes, Cardiac | 3 | 2010 | 1667 | 0.030 |
Why?
|
| Subtilisins | 1 | 2014 | 81 | 0.030 |
Why?
|
| Cognition | 1 | 2011 | 6988 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 1998 | 615 | 0.030 |
Why?
|
| Elasticity | 2 | 2007 | 655 | 0.030 |
Why?
|
| Health Status | 2 | 2022 | 4076 | 0.030 |
Why?
|
| Glycine | 1 | 2017 | 661 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2001 | 1185 | 0.030 |
Why?
|
| Proprotein Convertases | 1 | 2014 | 95 | 0.030 |
Why?
|
| Receptors, Leptin | 2 | 2006 | 350 | 0.030 |
Why?
|
| Cornea | 1 | 2001 | 1332 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 1998 | 642 | 0.030 |
Why?
|
| Mucin-3 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2012 | 40 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 1992 | 900 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 2747 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 238 | 0.030 |
Why?
|
| Infant | 5 | 2015 | 36157 | 0.030 |
Why?
|
| Patient Admission | 2 | 1998 | 1365 | 0.030 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 87 | 0.030 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2013 | 77 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 5811 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 451 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 299 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2014 | 393 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 126 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2013 | 170 | 0.030 |
Why?
|
| Myofibrils | 1 | 2013 | 141 | 0.030 |
Why?
|
| Minority Groups | 1 | 2020 | 1202 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1992 | 110 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 1988 | 4218 | 0.030 |
Why?
|
| Transaminases | 1 | 2013 | 199 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1988 | 3164 | 0.030 |
Why?
|
| Endonucleases | 1 | 2015 | 371 | 0.030 |
Why?
|
| GC Rich Sequence | 1 | 2012 | 18 | 0.030 |
Why?
|
| Binding Sites | 1 | 2001 | 6051 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2013 | 158 | 0.030 |
Why?
|
| Safflower Oil | 1 | 2012 | 29 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 289 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2878 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 993 | 0.030 |
Why?
|
| Spirometry | 1 | 2015 | 928 | 0.030 |
Why?
|
| Forensic Toxicology | 1 | 2011 | 5 | 0.030 |
Why?
|
| Drug Residues | 1 | 2011 | 7 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 1632 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2015 | 851 | 0.020 |
Why?
|
| Groin | 1 | 2012 | 106 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2012 | 96 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2016 | 566 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2015 | 1150 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 319 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2000 | 2486 | 0.020 |
Why?
|
| Image Enhancement | 2 | 2013 | 2881 | 0.020 |
Why?
|
| Suction | 1 | 1993 | 266 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2013 | 269 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 1993 | 289 | 0.020 |
Why?
|
| Hyperlipoproteinemia Type IV | 1 | 2011 | 5 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2002 | 3056 | 0.020 |
Why?
|
| Emulsions | 1 | 2012 | 152 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2015 | 850 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4325 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2006 | 1748 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2020 | 2553 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2011 | 106 | 0.020 |
Why?
|
| Granzymes | 1 | 2013 | 277 | 0.020 |
Why?
|
| Neurocan | 1 | 2011 | 21 | 0.020 |
Why?
|
| Globins | 1 | 2012 | 405 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2001 | 1604 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 261 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 982 | 0.020 |
Why?
|
| Duffy Blood-Group System | 1 | 2011 | 58 | 0.020 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 36 | 0.020 |
Why?
|
| Alpha-Globulins | 1 | 2010 | 26 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2001 | 2676 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2012 | 139 | 0.020 |
Why?
|
| Health Services Research | 1 | 2018 | 1808 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 1111 | 0.020 |
Why?
|
| Biometry | 1 | 2014 | 561 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 1927 | 0.020 |
Why?
|
| Environment | 2 | 2008 | 1123 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2011 | 141 | 0.020 |
Why?
|
| Thoracic Cavity | 1 | 2010 | 12 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1400 | 0.020 |
Why?
|
| Finland | 1 | 2012 | 607 | 0.020 |
Why?
|
| Arm | 1 | 2013 | 588 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 658 | 0.020 |
Why?
|
| Guidelines as Topic | 2 | 2011 | 1386 | 0.020 |
Why?
|
| New England | 1 | 2013 | 1050 | 0.020 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2010 | 63 | 0.020 |
Why?
|
| Shoulder | 1 | 2012 | 300 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1992 | 755 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 375 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2001 | 1521 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1999 | 2115 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2013 | 425 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2017 | 1231 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2447 | 0.020 |
Why?
|
| Aerosols | 1 | 1992 | 635 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 616 | 0.020 |
Why?
|
| Phospholipase C delta | 1 | 2009 | 7 | 0.020 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2011 | 343 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 1460 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1376 | 0.020 |
Why?
|
| Anal Canal | 1 | 2012 | 374 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 712 | 0.020 |
Why?
|
| Microcirculation | 1 | 2014 | 1272 | 0.020 |
Why?
|
| Hospital Costs | 1 | 1995 | 947 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 484 | 0.020 |
Why?
|
| Azetidines | 1 | 2010 | 142 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2010 | 177 | 0.020 |
Why?
|
| Nucleotides | 1 | 2012 | 453 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 1992 | 1156 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2010 | 208 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 69 | 0.020 |
Why?
|
| Echocardiography, Doppler | 2 | 2004 | 893 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 13442 | 0.020 |
Why?
|
| Ethics Committees, Research | 1 | 2010 | 196 | 0.020 |
Why?
|
| Fibrosis | 1 | 2016 | 2047 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2010 | 273 | 0.020 |
Why?
|
| Forecasting | 2 | 2015 | 2924 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2012 | 480 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 584 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2013 | 718 | 0.020 |
Why?
|
| Bronchi | 1 | 1993 | 846 | 0.020 |
Why?
|
| Glutamine | 1 | 2012 | 576 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2010 | 375 | 0.020 |
Why?
|
| Coronary Artery Bypass | 2 | 1996 | 2188 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2009 | 102 | 0.020 |
Why?
|
| Antioxidants | 1 | 1997 | 1669 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2002 | 574 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5780 | 0.020 |
Why?
|
| Indium Radioisotopes | 1 | 1988 | 113 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 2010 | 338 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 840 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 1022 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 496 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 1074 | 0.020 |
Why?
|
| Societies, Medical | 2 | 2013 | 3901 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3017 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2009 | 544 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2011 | 269 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2010 | 318 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2010 | 478 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 3451 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2009 | 141 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1557 | 0.020 |
Why?
|
| Cohort Effect | 1 | 2008 | 39 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2013 | 1864 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2015 | 1270 | 0.020 |
Why?
|
| Work of Breathing | 1 | 1988 | 56 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2008 | 613 | 0.020 |
Why?
|
| Adenylate Cyclase Toxin | 2 | 1984 | 25 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 744 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 584 | 0.020 |
Why?
|
| American Hospital Association | 1 | 2007 | 26 | 0.020 |
Why?
|
| Catheterization | 1 | 1993 | 1428 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2011 | 673 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1984 | 154 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1712 | 0.020 |
Why?
|
| Pertussis Toxin | 2 | 1984 | 176 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1133 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1525 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2017 | 2329 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5863 | 0.020 |
Why?
|
| Adenosine | 1 | 2012 | 805 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 981 | 0.020 |
Why?
|
| Policy | 1 | 2010 | 506 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 3965 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1992 | 1526 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1997 | 4140 | 0.020 |
Why?
|
| Tomography | 1 | 2009 | 411 | 0.020 |
Why?
|
| Germany | 1 | 2009 | 872 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2007 | 294 | 0.020 |
Why?
|
| Professional Competence | 1 | 2009 | 431 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3793 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2007 | 150 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 774 | 0.020 |
Why?
|
| alpha-Galactosidase | 1 | 2006 | 57 | 0.020 |
Why?
|
| Mitochondrial Myopathies | 1 | 2006 | 50 | 0.020 |
Why?
|
| Neutrophils | 1 | 1999 | 3763 | 0.020 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2006 | 77 | 0.020 |
Why?
|
| Wound Healing | 1 | 1997 | 2802 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2644 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1320 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2007 | 222 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 3606 | 0.020 |
Why?
|
| Patient Participation | 2 | 2010 | 1443 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2005 | 25 | 0.020 |
Why?
|
| China | 1 | 2012 | 2374 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 3837 | 0.020 |
Why?
|
| Demography | 2 | 2001 | 1643 | 0.020 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2006 | 123 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1997 | 2515 | 0.020 |
Why?
|
| Lauric Acids | 1 | 2004 | 9 | 0.020 |
Why?
|
| Sclerosis | 1 | 2005 | 210 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2005 | 123 | 0.020 |
Why?
|
| Zebrafish | 1 | 2016 | 3005 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 928 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 814 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 135 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2669 | 0.020 |
Why?
|
| Plethysmography, Whole Body | 1 | 2004 | 25 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 1000 | 0.020 |
Why?
|
| Tennessee | 1 | 2004 | 119 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2006 | 352 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2009 | 876 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2009 | 868 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 2481 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3794 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2008 | 5239 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 291 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2009 | 1814 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2009 | 12333 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1984 | 55 | 0.010 |
Why?
|
| Life Tables | 1 | 2004 | 364 | 0.010 |
Why?
|
| Aryldialkylphosphatase | 1 | 2004 | 64 | 0.010 |
Why?
|
| CHO Cells | 1 | 2007 | 1387 | 0.010 |
Why?
|
| Guanylyl Imidodiphosphate | 1 | 1983 | 37 | 0.010 |
Why?
|
| DNA Replication | 1 | 2011 | 1414 | 0.010 |
Why?
|
| Hyperemia | 1 | 2005 | 221 | 0.010 |
Why?
|
| Glucuronidase | 1 | 2005 | 202 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 2413 | 0.010 |
Why?
|
| Theophylline | 1 | 1984 | 131 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 412 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2007 | 607 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 2004 | 161 | 0.010 |
Why?
|
| Hyperhomocysteinemia | 1 | 2004 | 118 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2851 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2829 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1674 | 0.010 |
Why?
|
| Birth Order | 1 | 2004 | 95 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2004 | 153 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 462 | 0.010 |
Why?
|
| Weight Gain | 1 | 2014 | 2349 | 0.010 |
Why?
|
| ras Proteins | 1 | 2009 | 1054 | 0.010 |
Why?
|
| Chemokines, CX3C | 1 | 2003 | 12 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1496 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 2007 | 639 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2424 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5433 | 0.010 |
Why?
|
| Heart Atria | 1 | 2009 | 1333 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 427 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2007 | 609 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 2003 | 62 | 0.010 |
Why?
|
| Glycerol | 1 | 1984 | 275 | 0.010 |
Why?
|
| Atrial Premature Complexes | 1 | 2002 | 17 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1983 | 316 | 0.010 |
Why?
|
| Codon | 1 | 2004 | 600 | 0.010 |
Why?
|
| Acids | 1 | 2003 | 125 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2015 | 2045 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2011 | 1723 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 925 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2803 | 0.010 |
Why?
|
| India | 1 | 2009 | 2286 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9171 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1984 | 618 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 656 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3196 | 0.010 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2001 | 61 | 0.010 |
Why?
|
| Philosophy, Medical | 1 | 2002 | 79 | 0.010 |
Why?
|
| Adenosine Deaminase | 1 | 1984 | 251 | 0.010 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2007 | 574 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1894 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.010 |
Why?
|
| Metacarpus | 1 | 2001 | 36 | 0.010 |
Why?
|
| Ventricular Premature Complexes | 1 | 2002 | 108 | 0.010 |
Why?
|
| Heart Septal Defects | 1 | 2002 | 190 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.010 |
Why?
|
| New Jersey | 1 | 2001 | 295 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 398 | 0.010 |
Why?
|
| Medicare | 1 | 1999 | 6774 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2001 | 120 | 0.010 |
Why?
|
| Heart Block | 1 | 2002 | 384 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2006 | 865 | 0.010 |
Why?
|
| Physical Examination | 1 | 2007 | 1254 | 0.010 |
Why?
|
| Rabbits | 2 | 1984 | 4770 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2007 | 1431 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2004 | 991 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 733 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 673 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2013 | 3183 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1490 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 546 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8209 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 925 | 0.010 |
Why?
|
| Thrombospondin 1 | 1 | 2001 | 257 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3415 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2000 | 247 | 0.010 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2002 | 266 | 0.010 |
Why?
|
| Postmenopause | 1 | 2009 | 2511 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1984 | 1756 | 0.010 |
Why?
|
| Menopause | 1 | 2007 | 1645 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2004 | 879 | 0.010 |
Why?
|
| Tongue | 1 | 2002 | 403 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2358 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 1150 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 836 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8542 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1988 | 1230 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2011 | 5109 | 0.010 |
Why?
|
| Lung Compliance | 1 | 1998 | 200 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2002 | 426 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 7050 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9345 | 0.010 |
Why?
|
| Respiratory Muscles | 1 | 1998 | 142 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2010 | 3735 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3567 | 0.010 |
Why?
|
| Muscles | 1 | 2002 | 1573 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2001 | 654 | 0.010 |
Why?
|
| Rats | 2 | 2012 | 23716 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2005 | 1808 | 0.010 |
Why?
|
| Electromyography | 1 | 2002 | 1392 | 0.010 |
Why?
|
| Therapeutic Community | 1 | 1997 | 20 | 0.010 |
Why?
|
| Hospitals, State | 1 | 1997 | 28 | 0.010 |
Why?
|
| Diaphragm | 1 | 1998 | 351 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2002 | 808 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 225 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2004 | 1411 | 0.010 |
Why?
|
| Diabetic Neuropathies | 1 | 2000 | 405 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 1997 | 99 | 0.010 |
Why?
|
| Critical Illness | 1 | 2009 | 2709 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3316 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3088 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6520 | 0.010 |
Why?
|
| Disease Management | 1 | 2006 | 2506 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1650 | 0.010 |
Why?
|
| Respiration | 1 | 2002 | 1656 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16968 | 0.010 |
Why?
|
| Anistreplase | 1 | 1995 | 11 | 0.010 |
Why?
|
| Anxiety | 1 | 2010 | 4573 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2001 | 794 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 1 | 1997 | 319 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3708 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1994 | 40 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 1862 | 0.010 |
Why?
|
| Epitopes | 1 | 2001 | 2501 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2000 | 2635 | 0.010 |
Why?
|
| Neutropenia | 1 | 1999 | 885 | 0.010 |
Why?
|
| Gestational Age | 1 | 2002 | 3577 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 1997 | 429 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 2851 | 0.010 |
Why?
|
| HIV Infections | 1 | 1999 | 17342 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 3492 | 0.010 |
Why?
|
| Goals | 1 | 1997 | 708 | 0.010 |
Why?
|
| Cicatrix | 1 | 1997 | 785 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1988 | 4252 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1993 | 586 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1988 | 6345 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 1962 | 0.010 |
Why?
|
| Melanoma | 1 | 1988 | 5696 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1996 | 1723 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2001 | 3037 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1994 | 1436 | 0.000 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 1988 | 15 | 0.000 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 1998 | 1390 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6074 | 0.000 |
Why?
|
| Calorimetry, Indirect | 1 | 1988 | 174 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 2419 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 2002 | 4488 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1993 | 1331 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1997 | 8516 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1988 | 1972 | 0.000 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1998 | 3196 | 0.000 |
Why?
|
| Pain | 1 | 1998 | 5062 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 2088 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1983 | 3591 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 7995 | 0.000 |
Why?
|